Facing No US #Biosimilar Competitors, #Humira Grows by $3.8 Billion https://t.co/5d4IBaiDgR via @BiosimCenter @abbvie #BiosimilarNews
Facing No US #Biosimilar Competitors, #Humira Grows by $3.8 Billion https://t.co/5d4IBaiDgR via @BiosimCenter @abbvie #BiosimilarNews